Inventor
WU SHUNG C
US25 patents
⚠️ This page may combine multiple inventors who share the name “WU SHUNG C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BERLEX LAB
14 patentsUS5691364ANov 25, 1997
Benzamidine derivatives and their use as anti-coagulants
BERLEX LAB138 citations98
US6140351AOct 31, 2000
Ortho-anthranilamide derivatives as anti-coagulants
BERLEX LAB179 citations97
US6306884B1Oct 23, 2001
Benzamidine derivatives and their use as anti-coagulants
BERLEX LAB73 citations96
US6034103AMar 7, 2000
Benzamidine derivatives and their use as anti-coagulants
BERLEX LAB34 citations96
US5889005AMar 30, 1999
Benzamidine derivatives and their use for treating thrombotic diseases
BERLEX LAB42 citations96
US5883100AMar 16, 1999
Benzamidine derivatives and their use as anti-coagulants
BERLEX LAB36 citations96
US5877181AMar 2, 1999
Benzamidine derivatives and their use as anti-coagulants
BERLEX LAB39 citations96
US6350746B1Feb 26, 2002
Benzamidine derivatives and their use as anti-coagulants
BERLEX LAB25 citations92
US6004981ADec 21, 1999
Benzamidine derivatives and their use as anti-coagulants
BERLEX LAB21 citations92
US6380221B1Apr 30, 2002
Ortho-anthranilamide derivatives as anti-coagulants
BERLEX LAB33 citations91
US6498185B1Dec 24, 2002
Ortho-anthranilamide derivatives as anti-coagulants
BERLEX LAB14 citations82
US6479485B2Nov 12, 2002
Benzamidine derivatives and their use as anti-coagulants
BERLEX LAB12 citations82
US6686364B2Feb 3, 2004
Benzamidine derivatives and their use as anti-coagulants
BERLEX LAB10 citations74
US6465459B2Oct 15, 2002
Benzamidine derivatives and their use as anti-coagulants
BERLEX LAB9 citations74
BRISTOL MYERS SQUIBB CO
10 patentsUS6887870B1May 3, 2005
Heterocyclic sodium/proton exchange inhibitors and method
BRISTOL MYERS SQUIBB CO51 citations95
US7326705B2Feb 5, 2008
Heterocyclic sodium/proton exchange inhibitors and method
BRISTOL MYERS SQUIBB CO24 citations92
US6642252B2Nov 4, 2003
Acid derivatives useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO31 citations92
US8962660B2Feb 24, 2015
Oxabicyclo [2.2.2] acid GPR120 modulators
BRISTOL MYERS SQUIBB CO7 citations83
US6011059AJan 4, 2000
Acyl guanidine sodium/proton exchange inhibitors and method
BRISTOL MYERS SQUIBB CO14 citations74
US9518000B2Dec 13, 2016
Bicyclo [2.2.1] acid GPR120 modulators
BRISTOL MYERS SQUIBB CO4 citations73
US6160134ADec 12, 2000
Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
BRISTOL MYERS SQUIBB CO8 citations71
US6713467B2Mar 30, 2004
Acid derivatives useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO3 citations63
US9938222B2Apr 10, 2018
Cyclopropanecarboxylic acid GPR120 modulators
BRISTOL MYERS SQUIBB CO1 citations52
US10023519B2Jul 17, 2018
Cyclobutane containing carboxylic acid GPR120 modulators
BRISTOL MYERS SQUIBB CO0 citations42